Table 2 Likelihood of receiving testing
Tested by CBC or PGx | PGx testing only | |||
|---|---|---|---|---|
O.R. (95% CI) | p value | O.R. (95% CI) | p value | |
Drug type | ||||
Azathioprine | Ref. | Ref. | ||
Mercaptopurine | 0.84 (0.80–0.88) | < 0.05 | 0.95 (0.90–0.99) | < 0.05 |
Thioguanine | 0.56 (0.41–0.76) | < 0.05 | 0.39 (0.26–0.59) | < 0.05 |
Prescribing Dx or stop code | ||||
Dermatology | Ref. | Ref. | ||
Gastroenterology | 1.13 (1.02–1.26) | 0.25 | 0.91 (0.83–0.99) | 0.26 |
Hematology | 0.71 (0.55–0.91) | < 0.05 | 0.05 (0.04–0.07) | < 0.05 |
Oncology | 0.65 (0.52–0.82) | 0.07 | 0.05 (0.04–0.07) | < 0.05 |
Rheumatology | 0.19 (0.17–0.21) | < 0.05 | 0.12 (0.11–0.13) | < 0.05 |
Transplant | 0.76 (0.69–0.85) | 0.01 | 0.55 (0.51–0.61) | < 0.04 |
Other | 0.60 (0.39–0.91) | 0.23 | 0.07 (0.04–0.13) | < 0.05 |
Age | 0.99 (0.99–0.99) | < 0.05 | 0.99 (0.99–0.99) | < 0.05 |
Sex | ||||
Male | Ref. | Ref. | ||
Female | 0.95 (0.90–1.00) | 0.28 | 1.00 (0.95–1.04) | 0.92 |
Racea | ||||
White | Ref. | Ref. | ||
Black or African American | 1.30 (1.24–1.36) | < 0.05 | 1.24 (1.19–1.30) | < 0.05 |
Asian | 1.74 (1.42–2.14) | < 0.06 | 1.41 (1.18–1.69) | < 0.05 |
Native Hawaiian or Other Pacific Islander | 0.77 (0.65–0.91) | 0.13 | 0.89 (0.75–1.06) | 0.50 |
American Indian or Alaska Native | 1.16 (0.95–1.40) | 0.45 | 1.09 (0.90–1.32) | 0.65 |
Unknown | 0.97 (0.91–1.04) | 0.70 | 1.00 (0.93–1.07) | 1.00 |
Ethnicitya | ||||
Not Hispanic or Latino | Ref. | Ref. | ||
Hispanic or Latino | 1.16 (1.08–1.25) | < 0.05 | 1.08 (1.01–1.16) | 0.27 |
Unknown | 0.69 (0.63–0.76) | < 0.05 | 0.84 (0.76–0.93) | < 0.05 |